ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 152 filers reported holding ARCUS BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 3.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,035,728 | +61.3% | 221,257 | +82.9% | 0.01% | +50.0% |
| Q4 2022 | $2,501,536 | -20.4% | 120,964 | +0.7% | 0.01% | -25.0% |
| Q3 2022 | $3,142,000 | +76.3% | 120,108 | +70.8% | 0.01% | +100.0% |
| Q2 2022 | $1,782,000 | +769.3% | 70,333 | +1098.4% | 0.00% | – |
| Q3 2021 | $205,000 | -80.2% | 5,869 | -84.4% | 0.00% | -100.0% |
| Q2 2021 | $1,034,000 | -22.0% | 37,639 | -20.3% | 0.00% | 0.0% |
| Q1 2021 | $1,326,000 | -22.5% | 47,226 | -28.4% | 0.00% | -33.3% |
| Q4 2020 | $1,712,000 | +52.6% | 65,966 | +0.8% | 0.00% | +50.0% |
| Q3 2020 | $1,122,000 | -22.0% | 65,440 | +12.5% | 0.00% | 0.0% |
| Q2 2020 | $1,439,000 | +298.6% | 58,162 | +123.9% | 0.00% | +100.0% |
| Q1 2020 | $361,000 | +32.7% | 25,976 | -3.6% | 0.00% | – |
| Q4 2019 | $272,000 | – | 26,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |